MNMD Insider Transactions
| Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
|---|---|---|---|---|---|---|---|---|
| 2024-03-25 | Greenway Schond L. | officer: Chief Financial Officer | 211,057 | F-InKind | D | 5,560 | 9.78 | 54,377.00 |
| 2024-03-25 | Karlin Dan | officer: Chief Medical Officer | 358,452 | S-Sale | D | 6,578 | 9.50 | 62,491.00 |
| 2024-03-25 | Barrow Robert | director, officer: Chief Executive Officer | 580,202 | S-Sale | D | 16,519 | 9.50 | 156,930.00 |
| 2024-02-27 | Wernli Miri Halperin | officer: Executive President | 125,000 | A-Award | A | 125,000 | 4.98 | 622,500.00 |
| 2024-02-27 | Greenway Schond L. | officer: Chief Financial Officer | 150,000 | A-Award | A | 150,000 | 4.98 | 747,000.00 |
| 2024-02-27 | Sullivan Mark | officer: Chief Legal Officer | 125,000 | A-Award | A | 125,000 | 4.98 | 622,500.00 |
| 2024-02-27 | Karlin Dan | officer: Chief Medical Officer | 150,000 | A-Award | A | 150,000 | 4.98 | 747,000.00 |
| 2024-02-27 | Liao Carrie | officer: Chief Accounting Officer | 100,000 | A-Award | A | 100,000 | 4.98 | 498,000.00 |
| 2024-02-27 | Barrow Robert | director, officer: Chief Executive Officer | 400,000 | A-Award | A | 400,000 | 4.98 | 1,992,000.00 |
| 2023-12-26 | Karlin Dan | officer: Chief Medical Officer | 365,030 | S-Sale | D | 6,774 | 3.63 | 24,590.00 |
| 2023-12-26 | Barrow Robert | director, officer: Chief Executive Officer | 596,721 | S-Sale | D | 13,237 | 3.63 | 48,050.00 |
| 2023-12-26 | Greenway Schond L. | officer: Chief Financial Officer | 216,617 | S-Sale | D | 5,652 | 3.63 | 20,517.00 |
| 2023-09-25 | Barrow Robert | director, officer: Chief Executive Officer | 619,960 | S-Sale | D | 5,268 | 3.57 | 18,807.00 |
| 2023-09-25 | Barrow Robert | director, officer: Chief Executive Officer | 611,729 | S-Sale | D | 8,231 | 3.58 | 29,467.00 |
| 2023-09-25 | Karlin Dan | officer: Chief Medical Officer | 375,044 | S-Sale | D | 3,678 | 3.57 | 13,130.00 |
| 2023-09-25 | Karlin Dan | officer: Chief Medical Officer | 371,804 | S-Sale | D | 3,240 | 3.58 | 11,599.00 |
| 2023-09-25 | Greenway Schond L. | officer: Chief Financial Officer | 226,123 | S-Sale | D | 1,908 | 3.57 | 6,812.00 |
| 2023-09-25 | Greenway Schond L. | officer: Chief Financial Officer | 222,269 | S-Sale | D | 3,854 | 3.58 | 13,797.00 |
| 2023-08-25 | Greenway Schond L. | officer: Chief Financial Officer | 228,031 | S-Sale | D | 20,000 | 3.80 | 76,000.00 |
| 2023-06-27 | Barrow Robert | director, officer: Chief Executive Officer | 631,873 | S-Sale | D | 7,086 | 3.19 | 22,604.00 |
| 2023-06-27 | Barrow Robert | director, officer: Chief Executive Officer | 623,457 | S-Sale | D | 8,416 | 3.21 | 27,015.00 |
| 2023-06-27 | Karlin Dan | officer: Chief Medical Officer | 381,685 | S-Sale | D | 3,820 | 3.19 | 12,186.00 |
| 2023-06-27 | Karlin Dan | officer: Chief Medical Officer | 378,722 | S-Sale | D | 2,963 | 3.21 | 9,511.00 |
| 2023-06-27 | Greenway Schond L. | officer: Chief Financial Officer | 251,972 | S-Sale | D | 7,694 | 3.19 | 24,544.00 |
| 2023-06-27 | Greenway Schond L. | officer: Chief Financial Officer | 248,031 | S-Sale | D | 3,941 | 3.21 | 12,651.00 |
| 2023-06-21 | GRYSKA DAVID W | director | 37,594 | A-Award | A | 37,594 | 3.61 | 135,714.00 |
| 2023-06-21 | GRYSKA DAVID W | director | 13,851 | A-Award | A | 13,851 | 0.00 | 0.00 |
| 2023-06-21 | GRYSKA DAVID W | director | 13,131 | A-Award | A | 13,131 | 0.00 | 0.00 |
| 2023-06-21 | CRYSTAL ROGER | director | 27,267 | A-Award | A | 19,203 | 3.61 | 69,323.00 |
| 2023-06-21 | CRYSTAL ROGER | director | 19,623 | A-Award | A | 13,671 | 0.00 | 0.00 |
| 2023-06-21 | Krebs Andreas | director | 29,748 | A-Award | A | 19,203 | 3.61 | 69,323.00 |
| 2023-06-21 | Krebs Andreas | director | 15,107 | A-Award | A | 13,671 | 0.00 | 0.00 |
| 2023-06-21 | Vallone Carol A | director | 29,205 | A-Award | A | 19,203 | 3.61 | 69,323.00 |
| 2023-06-21 | Vallone Carol A | director | 16,544 | A-Award | A | 13,671 | 0.00 | 0.00 |
| 2023-06-21 | Bruhn Suzanne Louise | director | 27,267 | A-Award | A | 19,203 | 3.61 | 69,323.00 |
| 2023-06-21 | Bruhn Suzanne Louise | director | 19,623 | A-Award | A | 13,671 | 0.00 | 0.00 |
| 2023-06-21 | GRYSKA DAVID W | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2023-03-14 | Greenway Schond L. | officer: Chief Financial Officer | 259,666 | A-Award | A | 175,000 | 0.00 | 0.00 |
| 2023-03-14 | Wernli Miri Halperin | director, officer: Executive President | 185,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2023-03-14 | Liao Carrie | officer: Chief Accounting Officer | 101,895 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-04-13 | Sullivan Mark | officer: Chief Legal Officer | 200,000 | A-Award | A | 200,000 | 0.00 | 0.00 |
| 2023-04-13 | Sullivan Mark | officer | 0 | 0 | 0.00 | 0.00 | ||
| 2023-03-14 | Barrow Robert | director, officer: Chief Executive Officer | 638,959 | A-Award | A | 400,000 | 0.00 | 0.00 |
| 2023-03-14 | Liao Carrie | officer: VP, Controller&Acct Principal | 478,430 | A-Award | A | 75,000 | 0.00 | 0.00 |
| 2023-03-14 | Karlin Dan | officer: Chief Medical Officer | 385,505 | A-Award | A | 125,000 | 0.00 | 0.00 |
| 2023-03-14 | Wernli Miri Halperin | director, officer: Executive President | 1,375,000 | A-Award | A | 100,000 | 0.00 | 0.00 |
| 2023-03-14 | Greenway Schond L. | officer: Chief Financial Officer | 1,445,000 | A-Award | A | 175,000 | 0.00 | 0.00 |
| 2023-03-01 | Karlin Dan | officer: Chief Medical Officer | 260,505 | S-Sale | D | 3,577 | 3.51 | 12,555.00 |
| 2023-03-01 | Barrow Robert | director, officer: Chief Executive Officer | 238,959 | S-Sale | D | 8,273 | 3.51 | 29,038.00 |
| 2022-12-21 | Barrow Robert | officer: Chief Executive Officer | 247,232 | S-Sale | D | 3,861 | 2.69 | 10,386.00 |
| 2022-12-21 | Karlin Dan | officer: Chief Medical Officer | 264,082 | S-Sale | D | 1,211 | 2.69 | 3,258.00 |
| 2022-10-25 | Karlin Dan | officer: Chief Medical Officer | 265,937 | S-Sale | D | 541 | 2.81 | 1,520.00 |
| 2022-10-27 | Karlin Dan | officer: Chief Medical Officer | 265,293 | S-Sale | D | 644 | 3.00 | 1,932.00 |
| 2022-10-25 | Barrow Robert | officer: Chief Executive Officer | 251,093 | S-Sale | D | 1,207 | 2.81 | 3,392.00 |
| 2022-10-18 | Barrow Robert | officer: Chief Executive Officer | 252,300 | S-Sale | D | 1,220 | 3.11 | 3,794.00 |
| 2022-09-26 | Karlin Dan | officer: Chief Medical Officer | 267,118 | S-Sale | D | 565 | 5.51 | 3,113.00 |
| 2022-09-27 | Karlin Dan | officer: Chief Medical Officer | 266,478 | S-Sale | D | 640 | 5.87 | 3,757.00 |
| 2022-09-26 | Barrow Robert | director, officer: Chief Executive Officer | 253,520 | S-Sale | D | 1,264 | 5.51 | 6,965.00 |
| 2022-09-16 | Barrow Robert | director, officer: Chief Executive Officer | 254,784 | S-Sale | D | 1,350 | 7.26 | 9,801.00 |
| 2022-08-31 | Karlin Dan | officer: Chief Medical Officer | 267,683 | S-Sale | D | 1,204 | 11.67 | 14,051.00 |
| 2022-08-31 | Barrow Robert | officer: Chief Executive Officer | 256,134 | S-Sale | D | 1,228 | 11.67 | 14,331.00 |
| 2022-08-16 | Barrow Robert | officer: Chief Executive Officer | 3,860,438 | S-Sale | D | 20,350 | 0.68 | 13,838.00 |
| 2022-08-11 | CRYSTAL ROGER | director | 503,773 | A-Award | A | 503,773 | 0.00 | 0.00 |
| 2022-08-11 | CRYSTAL ROGER | director: | 120,968 | A-Award | A | 120,968 | 0.00 | 0.00 |
| 2022-08-11 | CRYSTAL ROGER | director | 120,968 | A-Award | A | 120,968 | 0.66 | 79,839.00 |
| 2022-08-11 | CRYSTAL ROGER | director | 89,286 | A-Award | A | 89,286 | 0.00 | 0.00 |
| 2022-08-11 | Bruhn Suzanne Louise | director: | 503,773 | A-Award | A | 503,773 | 0.00 | 0.00 |
| 2022-08-11 | Bruhn Suzanne Louise | director | 120,968 | A-Award | A | 120,968 | 0.66 | 79,839.00 |
| 2022-08-11 | Bruhn Suzanne Louise | director | 89,286 | A-Award | A | 89,286 | 0.00 | 0.00 |
| 2022-08-11 | Bruhn Suzanne Louise | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-08-11 | CRYSTAL ROGER | director: | 0 | 0 | 0.00 | 0.00 | ||
| 2022-07-25 | Karlin Dan | officer: Chief Medical Officer | 4,043,120 | S-Sale | D | 8,361 | 0.69 | 5,769.00 |
| 2022-07-25 | Barrow Robert | officer: Chief Executive Officer | 3,880,788 | S-Sale | D | 18,681 | 0.69 | 12,890.00 |
| 2022-07-18 | Barrow Robert | officer: Chief Executive Officer | 3,899,469 | S-Sale | D | 19,388 | 0.70 | 13,572.00 |
| 2022-06-27 | Barrow Robert | officer: Chief Executive Officer | 3,918,857 | S-Sale | D | 36,762 | 0.70 | 25,733.00 |
| 2022-06-27 | Karlin Dan | officer: Chief Medical Officer | 4,051,481 | S-Sale | D | 26,238 | 0.70 | 18,367.00 |
| 2022-06-16 | Barrow Robert | officer: Chief Executive Officer | 3,955,619 | S-Sale | D | 21,275 | 0.70 | 14,892.00 |
| 2022-06-01 | Makes Brigid | director | 643,804 | A-Award | A | 361,680 | 0.00 | 0.00 |
| 2022-06-01 | Makes Brigid | director | 194,358 | A-Award | A | 100,308 | 0.60 | 60,185.00 |
| 2022-06-01 | Makes Brigid | director | 158,706 | A-Award | A | 64,656 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director | 802,516 | A-Award | A | 774,673 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director | 161,587 | A-Award | A | 133,744 | 0.60 | 80,246.00 |
| 2022-06-01 | Vallone Carol A | director | 126,041 | A-Award | A | 98,198 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director | 62,196 | A-Award | A | 34,353 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director | 43,104 | A-Award | A | 43,104 | 0.00 | 0.00 |
| 2022-06-01 | Krebs Andreas | director | 759,701 | A-Award | A | 717,937 | 0.00 | |
| 2022-06-01 | Krebs Andreas | director | 175,508 | A-Award | A | 133,744 | 0.00 | 0.00 |
| 2022-06-01 | Krebs Andreas | director | 139,962 | A-Award | A | 98,198 | 0.00 | |
| 2022-06-01 | Krebs Andreas | director | 68,392 | A-Award | A | 28,628 | 0.00 | |
| 2022-06-01 | Krebs Andreas | director | 21,552 | A-Award | A | 21,552 | 0.00 | 0.00 |
| 2022-06-01 | Vallone Carol A | director: | 161,587 | A-Award | A | 133,744 | 0.00 | 0.00 |
| 2022-06-01 | Makes Brigid | director: | 643,804 | A-Award | A | 361,680 | 0.00 | 0.00 |
| 2022-06-01 | Krebs Andreas | director: | 68,392 | A-Award | A | 28,628 | 0.00 | 0.00 |
| 2022-05-23 | Greenway Schond L. | officer: Chief Financial Officer | 1,650,000 | A-Award | A | 1,650,000 | 0.78 | 1,287,000.00 |
| 2022-05-23 | Greenway Schond L. | officer: Chief Financial Officer | 1,270,000 | A-Award | A | 1,270,000 | 0.00 | 0.00 |
| 2022-05-27 | Karlin Dan | officer: Chief Medical Officer | 4,077,719 | S-Sale | D | 9,555 | 0.82 | 7,835.00 |
| 2022-05-25 | Barrow Robert | officer: Chief Executive Officer | 3,976,894 | S-Sale | D | 18,415 | 0.77 | 14,180.00 |
| 2022-05-25 | Karlin Dan | officer: Chief Medical Officer | 4,087,274 | S-Sale | D | 8,242 | 0.77 | 6,346.00 |
| 2022-05-11 | Makes Brigid | director: | 94,050 | J-Other | A | 67,678 | 0.00 | 0.00 |
| 2022-05-23 | Greenway Schond L. | officer: Chief Financial Officer | 1,270,000 | A-Award | A | 1,270,000 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
